2025 annual financial data
Ascendis Pharma 2025 Operating margin
Ascendis Pharma 2025 operating margin with verified reported values.
Direct answer
Operating margin was -18.92%.
Operating income was -130,892,766 EUR and net income was -219,034,140 EUR.
Operating cash flow was 51,769,836 EUR.
Get free Ascendis Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 691,710,419 EUR
- Operating income
- -130,892,766 EUR
- Net income
- -219,034,140 EUR
- Operating cash flow
- 51,769,836 EUR